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Fragile X-associated tremor ataxia syndrome
(FXTAS) results from a CGG repeat expansion in
the 50 UTR of FMR1. This repeat is thought to elicit
toxicity as RNA, yet disease brains contain ubiqui-
tin-positive neuronal inclusions, a pathologic hall-
mark of protein-mediated neurodegeneration. We
explain this paradox by demonstrating that CGG
repeats trigger repeat-associated non-AUG-initiated
(RAN) translation of a cryptic polyglycine-containing
protein, FMRpolyG. FMRpolyG accumulates in ubiq-
uitin-positive inclusions in Drosophila, cell culture,
mouse disease models, and FXTAS patient brains.
CGG RAN translation occurs in at least two of three
possible reading frames at repeat sizes ranging
from normal (25) to pathogenic (90), but inclusion
formation only occurs with expanded repeats. In
Drosophila, CGG repeat toxicity is suppressed
by eliminating RAN translation and enhanced by
increased polyglycine protein production. These
studies expand the growing list of nucleotide repeat
disorders in which RAN translation occurs and pro-
vide evidence that RAN translation contributes to
neurodegeneration.
INTRODUCTION
A diverse group of human neurological disorders result from
nucleotide repeat expansions (Orr and Zoghbi, 2007). These
mutations can cause disease by protein gain-of-function, protein440 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.loss-of-function, or RNA gain-of-function mechanisms. For
dominantly inherited repeat expansion disorders, defining
whether the gain-of-function toxicity is elicited as RNA or as pro-
tein has traditionally depended on whether the repeat resides
in an open reading frame (ORF) within an exon. For example, in
Huntington’s disease and other polyglutamine neurodegenera-
tive disorders, expansion of exonic CAG repeats encoding
polyglutamine promotes aggregation and alterations in the
native properties of disease proteins (Orr and Zoghbi, 2007). In
contrast, in myotonic dystrophy type 1, a CUG repeat expansion
in the 30 UTR of the DMPK gene causes toxicity predominantly
as RNA (Cooper et al., 2009). The CUG repeat forms a hairpin
structure that binds and sequesters certain splicing factors while
also triggering activation of other pathogenic cascades.
Recently, however, the line separating RNA and protein gain-
of-function nucleotide repeat diseases has begun to blur. RNA-
mediated toxicity has now been proposed to contribute to
polyglutamine diseases (Li et al., 2008) and bidirectional
transcription through expansions can lead to repeats in both
‘‘coding’’ and ‘‘noncoding’’ mRNAs, raising the possibility that
multiple toxic species may be produced from a single expansion
(Ladd et al., 2007; Moseley et al., 2006; Wilburn et al., 2011).
Moreover, evidence now suggests that repeats can be trans-
lated into proteins even if they do not reside in an AUG-initiated
open reading frame (Zu et al., 2011). This repeat-associated non-
AUG-initiated (RAN) translation can occur in all three possible
ORFs of a given transcript, leading to numerous potentially toxic
entities from a given repeat sequence (Pearson, 2011). RAN
translation was recently shown to occur through the C9orf72
GGGGCC repeat expansion that causes ALS and frontotemporal
dementia (Ash et al., 2013; DeJesus-Hernandez et al., 2011;
Mori et al., 2013; Renton et al., 2011). These new findings raise
key questions about how RAN translation occurs and whether
it contributes directly to neurodegeneration. As the expected
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RAN Translation in FXTASmechanisms of toxicity differ depending on whether the inciting
agent is RNA or protein, defining the critical toxic species in each
repeat expansion disorder is an important step toward therapeu-
tic development.
To explore the respective roles of RNA and RAN translation
in repeat-associated neurodegeneration, we investigated fragile
X-associated tremor ataxia syndrome (FXTAS), a common in-
herited cause of gait disorder, dementia, and tremor (Jacque-
mont et al., 2004). FXTAS is caused by a modestly expanded
CGG nucleotide repeat (55–200) in the 50 UTR of the fragile
X mental retardation gene, FMR1. Much larger expansions of
the same repeat cause fragile X syndrome, the most common
inherited form of mental retardation, by silencing FMR1 tran-
scription (Penagarikano et al., 2007). By contrast, in FXTAS
patients and animal models, the moderately expanded CGG
repeat is associated with elevated FMR1 mRNA expression,
neurodegeneration, and intranuclear neuronal inclusions that
contain the CGG repeat mRNA and various proteins (Greco
et al., 2006; Tassone et al., 2004). Research to date has focused
on how the repeat might trigger neurodegeneration through an
RNA mechanism (Jin et al., 2007; Sellier et al., 2010; Sofola
et al., 2007), but critical aspects of disease pathology are not
explained by a purely RNA-mediated process. Notably, the
inclusions in FXTAS brains differ from those seen in other
RNA-mediated disorders: they are large, ubiquitinated aggre-
gates containing chaperone proteins such as HSP70 and many
other proteins that do not interact directly with CGG repeat
mRNA (Greco et al., 2006; Iwahashi et al., 2006). The inclusions
of FXTAS instead more closely resemble neuronal intranuclear
inclusions seen in polyglutamine diseases and other protein-
mediated neurodegenerative disorders (Williams and Paulson,
2008).
Here we explain this paradox. We demonstrate that the CGG
repeat expansion in FXTAS triggers RAN translational initiation
within the 50 UTR of FMR1 mRNA through an AUG-independent
mechanism. The translated product, a cryptic polyglycine-
containing protein we name FMRpolyG, is toxic in Drosophila
and in human cell lines, capable of driving intranuclear inclusion
formation, and present in FXTAS patient brains. The ability
to produce FMRpolyG also explains pathologic discrepancies
between two mouse models of FXTAS and directly influences
the toxicity of CGG repeat constructs in Drosophila. Our findings
support a disease model in which RAN translation of an
expanded polyglycine protein contributes to FXTAS disease
pathogenesis and suggest novel approaches toward therapeutic
development in this and other neurodegenerative disorders.
RESULTS
Repeat-Associated Non-AUG-Initiated Translation and
Inclusion Formation in a Drosophila Model of FXTAS
To explore the mechanism of inclusion formation in FXTAS, we
utilized a Drosophila model of CGG repeat-mediated neuro-
degeneration inwhich the 50 UTR from an FXTAS patient contain-
ing 90 CGG repeats is placed upstream of the coding region
for GFP (Figure 1A; Jin et al., 2003; Todd et al., 2010). Initially
designed to evaluate RNA-mediated toxicity, the (CGG)90
GFP-expressing flies exhibit repeat length-dependent retinaldegeneration (Jin et al., 2003). Remarkably, GFP-positive inclu-
sions accumulate in (CGG)90 GFP-expressing flies but not in flies
expressing GFP alone (Figure 1B). These inclusions form in
both the nucleus and cytoplasm and immunostain positively
for ubiquitin and the chaperone HSP70 (Figures 1C and 1D).
CGG repeat RNA forms foci in FXTAS patients and in cell
models of disease (Sellier et al., 2010; Tassone et al., 2004).
We therefore evaluated whether the observed GFP inclusions
in (CGG)90 GFP-expressing flies colocalize with RNA foci.
Multiple nuclear and cytoplasmic RNA foci were observed in
retinal sections probedwith a Cy5-(CCG)6 RNA probe (Figure 1E,
see Figure S1A available online) (Sellier et al., 2010). Only a frac-
tion (43%) of RNA foci colocalized with GFP-positive inclusions
(Figure 1F).
In principle, the GFP inclusions could result from general
impairment of the ubiquitin proteasome system (UPS) by CGG
repeat-containing mRNA/protein complexes. Arguing against
this possibility, however, is the fact that coexpression of the
temperature-sensitive b2 proteasomal subunit mutant DTS7
with GFP did not result in GFP inclusions (Figure S1B and data
not shown), whereas it did induce inclusion formation by a
more aggregate-prone fluorescent reporter, DsRed (Figure S1C).
We next crossed flies expressing (CGG)90 GFP with flies ex-
pressing DsRed. In this cross, if GFP inclusions resulted from a
general toxic effect of the repeat, then the aggregation-prone
DsRed should also form inclusions that coaggregate with GFP.
These flies, however, developedGFP-positive inclusions without
coaggregation of DsRed, suggesting that inclusion formation
requires the CGG repeat to be present in the same mRNA that
encodes GFP (Figure S1D). The presence of GFP inclusions
prompted us to test whether enhancing or suppressing protein
quality control pathways could modulate retinal degeneration
in (CGG)90 GFP-expressing flies. Consistent with a protein-
mediated effect, retinal degeneration was enhanced by co-
expressing the temperature-sensitive proteasomal subunit
mutation DTS5 (b6 subunit) and suppressed by coexpression
of the chaperone protein HSP-70 (Figure 1G; Jin et al., 2003;
data not shown).
A recent report suggests that CAG repeats can trigger uncon-
ventional translation initiation (RAN translation) in the absence of
an AUG start codon (Zu et al., 2011).We therefore askedwhether
CGG repeats trigger RAN translation upstream of, and in frame
with, the GFP coding sequence to generate a higher molecular
weight (HMW) GFP fusion protein that is prone to aggregate.
Indeed, western blot analysis of (CGG)90 GFP Drosophila lysates
revealed an additional GFP species 12 kDa larger than GFP
(Figure 1H, arrow). Sequence analysis ruled out an unexpected
upstream ATG mutation in the GFP coding sequence or loss of
the GFP stop codon as the basis for this HMW GFP (full
sequence is in Figure S1E). Stringent immunoprecipitations
from (CGG)90 GFP lysates (Figure S1F) also excluded ubiquitina-
tion as the cause of the HMW GFP protein.
Tandemmass spectroscopy (MS) of GFP immunoprecipitates
from (CGG)90 GFP Drosophila lysates confirmed the presence
of an unconventional translation product. Three peptides were
identified that correspond to the predicted protein sequence
downstream of the repeat if the FMR1 50 UTR were translated
(Figure 1I). These peptides were not detected in flies expressingNeuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc. 441
(CGG)90 GFP DTS5
(CGG)90 GFP
x DTS5
 GFP         (CGG)90 GFP
GFP Ubiquitin Merge + DAPI GFP HSP70 Merge 
(CGG)90
Human FMR1 5’UTR/exon1
 GFP
AUG
 GFP
Expected protein product
 GFP(Gly)90
RAN translation product
UAS UASUASUAS
TSS
> >
GFP CGG RNA Merge 
Ub HSP70 RNA foci
0
20
40
60
80
100
%
 c
ol
oc
al
iz
at
io
n
 -      +       -       +       -      +
3 hr 20 hr 20 hr
(CGG)90 GFP GFP
LS:
37
25
*RAAAVTETPLPGGVRQRGGGGGGGGGGGGGGGGGGGGGG
GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG
GGGGGGGGGGGGGGGGGGGGGGGGGGGGWASSARSPPLGG
GLPALVGLKRRWRSWWWKCGAPRALSTRYLALGQAQPNSA
VDGTAGPGSIATMVSKGEELFTGVVPILVELDGDVNGHK
FSVSGEGEGDATYGK…(GFP sequence)
37
25
50
GFP
GFP
(CGG)90
GFPØ
Actin
DC
F
I J
E
A B
G
H
Figure 1. CGG RAN Translation in a Drosophila Model of FXTAS
(A) Schematic of (CGG)90 GFP fly construct. A polyglycine protein is produced in these flies by RAN translation proceeding through the CGG repeat. Black
sequence represents vector derived and red sequence represents human derived. Thicker red line indicates CGG repeat. The black arrow shows the expected
AUG translational initiation site for GFP and the expected product. The red bracket and arrow show the RAN translational initiation region for the polyglycine-GFP
fusion protein identified by tandem MS. TSS is the presumed transcription start site.
(B) GFP inclusions in oomatidia from (CGG)90 GFP-, but not GFP-, expressing flies.
(C) Confocal micrographs of transverse retinal sections from gmr-GAL4; (CGG)90 GFP flies reveal nuclear and cytoplasmic inclusions that colocalize with
ubiquitin.
(D) (CGG)90 GFP inclusions partially colocalize with HSP70.
(E) In situ hybridization using a Cy5(CCG)6 RNA probe on transverse retinal sections. CGG RNA foci form in the nucleus and cytoplasm of (CGG)90 GFP flies and
are either distinct from (arrowhead), or overlap with (arrow), GFP inclusions.
(F) Quantification of colocalization of GFP aggregates with ubiquitin, HSP70, and CGG RNA foci. Error bars represent 95% confidence interval.
(G) Coexpression of proteasomal subunit mutant DTS5 with (CGG)90 GFP enhances retinal degeneration at 28C.
(H) A HMW band is seen with anti-GFP antibody (arrow) in lysates from (CGG)90 GFP-expressing flies. Lane 1, gmr-GAL4 flies (negative control); lane 2,
gmr-GAL4; uas GFP; lane 3, gmr-GAL4; uas (CGG)90 GFP.
(I) TandemMS analysis of the HMWGFP band identifies three peptides (yellow) indicating that translation initiates above the repeat. Green sequence represents
GFP. ‘‘*’’ indicates that predicted peptides above the indicated AA sequence were not detected.
(J) The HMW GFP product is selectively digested by the polyglycine endopeptidase, lysostaphin (LS).
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RAN Translation in FXTASGFP alone and are not predicted to exist in the Drosophila prote-
ome. Based on the apparent molecular weight of the observed
product, the identified peptide sequences corresponding to
the 50 UTR, and the reading frame of GFP, we conclude that
the repeat is translated in the GGC reading frame to produce a
90 amino acid polyglycine stretch at the N terminus of the pro-
tein, with translation initiating just 50 to the repeat. Consistent442 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.with this, further analysis identified a fourth peptide immediately
N-terminal to the polyglycine repeat (Figure 1I) but no other
peptides above this region.
No polyglycine fragment was detected by tandemMS, reflect-
ing the lack of trypsin cleavage sites in expanded polyglycine.
To confirm that the translation product contains polyglycine,
we treated immunoprecipitates with lysostaphin, a specific
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Figure 2. CGG Repeats Trigger RAN Translation and Inclusion Formation in Mammalian Cells
(A) Schematic of (CGG)88 GFP vector and mutations introduced in various constructs. Arrowhead shows the site of additional base insertions to shift the frame of
GFP relative to the repeat. Red box reflects stop codon introduced in the +1 (Gly) frame. Full sequences of all constructs are shown in Table S1.
(B) In COS cells 72 hr after transfection with (CGG)88 GFP constructs, inclusions were observed when the CGG repeat was located in the +1(Gly) frame, but not in
native CGG +0 (Arg) frame. Right panel includes a stop codon inserted between the repeat and the GFP coding sequence.
(C) COS cell lysates 72 hr after transfection with indicated plasmids, probed on western blot with antibodies to GFP or Tubulin.
(D) Quantification of inclusion formation by (CGG)88 +1 GFP in COS or SY5Y neuroblastoma cells 24, 48, and 72 hr after transfection.
(E) Confocal microscopy showing inclusion in an SY5Y cell expressing (CGG)88 +1 GFP, stained for ubiquitin (red) and costained for DAPI (blue).
(F) An ATG start site placed upstream of the repeat in the +1 (Gly) frame (ATG-(CGG)88 +1 GFP) increases translation of the HMW GFP product.
(G) ATG-(CGG)88 GFP enhances GFP inclusion formation similar to levels seen with a polyglutamine peptide fused to GFP (Q80-GFP), an aggregation-prone
positive control.
(H) Comparison of percentage of GFP-positive cells with inclusions upon expression of ATG-(CGG)88 GFP or Q80-GFP 24 hr after transfection. For (D) and (H),
error bars represent SEM.
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RAN Translation in FXTASpentaglycine endopeptidase (Huber and Schuhardt, 1970).
Lysostaphin successfully cleaved the HMW GFP species from
(CGG)90 GFP lysates but had no effect on GFP alone, confirming
the presence of a polyglycine repeat (Figure 1J).
RAN Translation Produces a Polyglycine-Containing
Protein in Mammalian Cells
Zu et al. (2011) recently described RAN translation triggered
by CAG/CUG repeat expansions in which translation initiates in
all three possible reading frames, beginning within the hairpin
itself. To test whether a similar phenomenon occurs with CGG
repeat expansions, we transfected COS cells or SY5Y neuro-
blastoma cells with a construct containing the FMR1 50 UTRfrom an FXTAS patient with 88 CGG repeats placed upstream
of GFP (Figure 2A, Table S1). Importantly, this construct differs
from the (CGG)90 GFP fly sequence in that the GFP start codon
resides in theCGGarginine-encoding frame relative to the repeat
(specified as +0 in all figures). This frame recapitulates the
relationship of the repeat to the FMRP ORF in FMR1 mRNA. In
contrast, the GFP start codon in the Drosophila model resides
in theGGCglycine-encoding frame (specified as +1 in all figures).
For consistency, the repeat is referred to as CGG in all figures
regardless of the frame in which it is translated, with modifiers
placed before or after the repeat to indicate the relevant ORF
and protein product and any introduced sequence changes.
The sequences of all constructs are included in Table S1.Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc. 443
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RAN Translation in FXTASExpression of the (CGG)88 +0GFP construct led to diffuseGFP
expression in transfected cells (Figure 2B), as previously re-
ported (Arocena et al., 2005). To test whether RAN translation
might initiate in other reading frames through the repeat, we
added one or two bases between the CGG repeat and the
ATG start codon of GFP: +1 (GGC, glycine-encoding) and +2
(GCG, alanine-encoding). As in (CGG)90 GFP flies, the +1 (Gly)
frame induced GFP inclusions in COS and SY5Y cells that accu-
mulated over time (Figures 2B and 2D) and were predominantly
intranuclear and ubiquitin positive (Figure 2E). Predictably,
placing a stop codon after the repeat but before the GFP start
site blocked GFP inclusion formation in the +1 (Gly) frame (Fig-
ure 2B). Consistent with the lack of an HMW FMRP species in
FXTAS patients and animal models, no GFP-positive inclusions
were identified in the +0 frame, despite the absence of inter-
vening stop codons between the repeat and the ATG initiation
codon of GFP. To test for the appearance of similar RAN trans-
lation products in mammalian cells as observed in Drosophila,
we performed western blots on cell lysates 72 hr after transfec-
tion with each construct. An HMW GFP species was produced
only in the +1 (Gly) frame and was no longer produced when a
stop codon was placed between the repeat and the GFP start
codon (Figure 2C). With the (CGG)88 +1 GFP construct, this
HMW GFP species constituted 10% of the total cellular pool
of GFP.
In a parallel set of experiments, we generated constructs in
which GFP lacked its canonical start codon. As expected, this
mutation markedly reduced the production of GFP in transfected
cells, but when a 55 CGG repeat sequence was inserted up-
stream of this ATG-less GFP, placing the repeat in the glycine
(+1)-encoding frame relative to GFP, the number of GFP-positive
cells recovers to 60% of that seen with ATG-GFP (Figures S2A
and S2B). In contrast, placing the CGG repeat in the arginine
(+0)-encoding frame did not significantly increase the number
of GFP-positive cells (Figures S2A and S2B). These findings
correlated with production of RAN translation products as
assessed by western blot: the HMW-GFP protein level was
10% of that produced from GFP alone, while translation prod-
ucts from the +0 (Arg) construct were below the limit of detection
(Figure S2C).
Studies comparing the aggregation properties of homopoly-
meric peptides suggest that small stretches of polyglycine are
not prone to aggregation (Oma et al., 2004). To evaluate the
aggregation properties of an expanded polyglycine-containing
protein in FXTAS, we introduced an ATG start site upstream of
the repeat in the glycine frame fused to GFP (ATG- (CGG)88 +1
GFP). Incorporation of a canonical start site markedly increased
production of the HMW GFP (Figure 2F), leading to inclusion
formation in most cells 24 hr after transfection, which is com-
parable to the rate of inclusion formation seen when expanded
polyglutamine is fused to GFP (Q80 GFP, Figures 2G and 2H).
Because the risk of developing FXTAS increases with larger
repeats (Leehey et al., 2008), we evaluated the impact of repeat
length on the production and aggregation of HMW GFP. The
normal FMR1 repeat in humans is between 20 and 45 CGGs,
usually interrupted by one or two intervening AGGs. Constructs
with 30, 50, or 88 CGG repeats in the +1 (Gly) frame with GFP all
resulted in HMW GFP production (Figure 3A). Remarkably, pro-444 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.duction of the RAN translation product appeared to increasewith
decreasing repeat size, which may reflect differences in the
transfer efficiency to PVDF membrane or greater translational
efficiency for GFP and HMW GFP with shorter repeats (Chen
et al., 2003). In contrast, aggregation decreased with decreasing
repeat size, such that inclusions were infrequent at 50 repeats
and nearly absent at 30 CGG repeats, suggesting a repeat length
dependence to aggregation (Figures 3B and 3C). This repeat
length dependence to inclusion formation was consistent
across numerous cell types including primary cortical neurons
(Figure S2D). Consistent with published studies, longer repeats
were also associated with decreased cellular viability (Fig-
ure S2E; Arocena et al., 2005; Handa et al., 2005; Sellier et al.,
2010).
RAN Translation of Polyglycine Protein Initiates 50 to the
CGG Repeat
To elucidate the mechanism by which RAN translation initiation
occurs, we created a series of mutations in the sequence 50 to
the repeat to determine the minimal requirements for initiation.
We first introduced a stop codon at 6 bp, 12 bp, 21 bp, or
63 bp from the start of the CGG repeat (Figure 3D). Stop co-
dons placed at 6 bp or 12 bp prevented the appearance of
GFP-positive inclusions and HMW GFP (Figures 3D–3F). In
contrast, placement of a stop codon at 21 or 63 bp did not
block production of HMW GFP, suggesting that RAN translation
initiates between 21 and 12 bases 50 of the CGG repeat
(Figure 3D).
The bias toward translation in the glycine reading frame sug-
gested preferred initiation at a specific non-AUG start site. A
plausible explanation is the use of a specific alternative start
codon as the translational origin rather than initiation within
the hairpin itself. However, serially mutating each potential
alternative start codon (i.e., ‘‘near-AUG’’ codons, differing by
a single base from AUG) in the glycine frame within 60 bp 50
of the CGG repeat did not eliminate production of HMW GFP
(Figure 3G and data not shown). This result suggests either
that a near-AUG codon is not needed to initiate translation or
that multiple, different near-AUG codons proximal to the repeat
can be utilized, so that eliminating any one near-AUG codon is
not sufficient to prevent translation. To address this latter pos-
sibility, we placed a stop codon at 21 bp, which by itself does
not prevent production of HMW GFP (Figure 3H), and mutated
the only potential near-AUG codon downstream of this stop
codon, a GUG codon at 11 bp. Mutating this GUG codon
to GAG by itself had no impact on HMW GFP production but,
combined with the stop codon at 21, HMW GFP production
was lost (Figure 3H). This result suggests that, at least for
some sequence contexts, a near-AUG codon close to the
repeat is required for CGG RAN translation initiation, but the
specific sequence 50 to the repeat is less critical. To evaluate
this, we deleted 48 nt just 50 proximal to the CGG repeat, which
impaired production of HMW GFP (Figure 3I). Deleting 91 nt 50
proximal to the repeat nearly eliminated HMW GFP production,
which could reflect the importance of the specific sequence
just proximal to the repeat or represent a consequence of
shortening the distance between the transcription start site
and the repeat (Figure 3I).
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Figure 3. CGG RAN Translation in Glycine Reading Frame Occurs at Normal Repeat Lengths, Initiates before the Repeat, and Does Not
Require a Specific Non-AUG Codon
(A) RAN translation occurs even with shorter repeats in the +1 (Gly) frame.
(B) Representative fluorescent micrographs of cells transfected with (CGG)n +1 GFP constructs with the indicated number of repeats.
(C) Percent transfected COS cells with GFP+ inclusions 72 hr after transfection of (CGG)n +1 GFP of the indicated repeat lengths.
(D) Top: schematic of (CGG)n +1GFP construct with location of introduced stop codonmutations. Bottom: western blot of cell lysates 72 hr after transfection with
the indicated constructs. Placing a stop codon 6 or 12 bp 50 to the repeat inhibits production of HMW GFP.
(E) Fluorescent micrographs of COS cells expressing (CGG)88 +1 GFP or stop@-12 (CGG)94 +1 GFP, 72 hr after transfection.
(F) Quantification of GFP inclusion formation in the presence or absence of a stop codon 12 bp 50 to the CGG repeat.
(G) Top: schematic demonstrating position of specific mutations in ‘‘near-AUG’’ codons that might serve as alternative start sites for CGG RAN translation in
the +1 frame. Bottom: western blot of lysates from cells expressing the indicated constructs demonstrates that eliminating any single near AUG codon is
insufficient to block RAN translation.
(H) Top: schematic demonstrating position of stop codon and near AUG codon mutation introduced into (CGG)n +1 GFP construct. Bottom: the elimination of a
near AUG codon at 11 (lane 2) or the presence of a stop codon at 21 (lane 3) allows HMWGFP translation, but combining these mutations (lane 4) eliminates
HMW GFP production.
(I) Top: schematic demonstrating deletion mutations that remove 48 or 91 nt just 50 proximal to the repeat. Bottom: western blot demonstrating that removal of
proximal sequence partially or completely impedes RAN translation in the +1 (Gly) frame. For this and other figures, differing sizes of the HMWGFP-positive bands
reflect repeat instability incurred during cloning; repeat size is shown below theGFP blot for each lane. Positions of specificmutations are defined relative to the 50
start of the repeat. Full sequences of all constructs are in Table S1. **p < 0.001 for trend, one-way ANOVA, *p < 0.001 versus GFP, yp < 0.001 versus (CGG)88 +1
GFP, t test. For (C) and (F), error bars represent SEM.
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Figure 4. A RAN Translation Product Is Also
Produced in the Alanine Frame
(A) Schematic of (CGG)88 +2 GFP construct. Green
arrowhead indicates where an intervening stop
codon was removed. Red arrowheads indicate
introduced stop codons.
(B) Unconventional translation resulting in a
discrete HMW-GFP species and aggregated pro-
tein in the stack is detected in the +2 (GCG,
alanine-encoding) frame when an intervening stop
codon is removed.
(C) No GFP inclusions are observed in +2 (Ala)
constructs even when the intervening stop codon
is removed.
(D) HMW polyalanine product is absent with
shorter CGG repeats.
(E) In +2 frame constructs, introduction of a stop
codon at8 bp (in the +2 frame) does not eliminate
the RAN translation product. A stop codon at
6 bp (in the +1 frame) reduces but does not
eliminate HMW GFP.
(F) Three hour digestion of GFP immunoprecipi-
tates with Lysostaphin eliminates the HMW
species in the +1 (Gly) frame but not in the +2 (Ala)
frame.
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RAN Translation in FXTASRAN Translation Also Occurs in the Alanine Reading
Frame
RAN translation associated with CGG repeats was not restricted
to the glycine frame. In the +2 (GCG, alanine-encoding) frame,
removing an in-frame stop codon between the repeat and the
GFP coding sequence led to an HMW GFP band and aggre-
gated protein (Figures 4A and 4B), although GFP-positive inclu-
sions were not seen in transfected cells (Figure 4C). The +2 (Ala)
frame HMW GFP species electrophoreses as a slightly smaller
protein than what is seen with identical sized repeats in +1
(Gly) frame constructs, suggesting a different site of initiation
(Figure 4B). In contrast to our results in the +1 (Gly) frame,
reducing the repeat size to 30 CGGs eliminated expression of
HMW GFP in the +2 (Ala) frame (Figure 4D). When a stop codon
was introduced in the +2 (Ala) frame at 8 bp from an expanded
(CGG)88 repeat, expression of the HMW GFP persisted (Fig-
ure 4E). This result could reflect translational initiation in
the +1 (Gly) frame followed by a frameshift into the +2 (Ala)
frame, as frameshifts are known to occur with longer CAG
repeat expansions (Stochmanski et al., 2012). To test this pos-
sibility, we introduced an upstream stop codon (6 bp) in
the +1 (Gly) frame while placing the downstream GFP sequence
in the +2 (Ala) frame. This did not eliminate expression of an
HMW GFP product (Figure 4E). To further exclude a Gly to Ala
frame shift, we incubated lysates from cells expressing
(CGG)88 +1 GFP or (CGG)88 +2 GFP with lysostaphin. Lysosta-
phin degraded HMW GFP produced in the +1 (Gly) frame but
not in the +2 (Ala) frame (Figure 4F). We conclude that RAN
translation associated with CGG repeats in the FMR1 50 UTR
occurs in at least two of three possible reading frames, but
the constraints on translational initiation appear to differ for
these two frames.446 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.The FMR1 50 UTR Is Engaged with Translating
Ribosomes
CGG RAN translation in Drosophila and transfected mammalian
cells suggests that unconventional translation may also occur in
FXTAS patients. To explore this possibility, we first assessed
whether the 50 UTR of FMR1mRNA is associated with translating
ribosomes by querying ribosome profiling data sets previously
generated in human cell lines (Guo et al., 2010; Hsieh et al.,
2012; Ingolia et al., 2012). This technique combines ribosomal
foot printing with next-generation sequencing to identify sites
of active translation. In examining the distribution of ribosomes
on FMR1 mRNA in published data sets, we observed that most
sequence reads occurred, as expected, over coding regions of
the FMR1 mature mRNA sequence (Figure 5A), with few if any
reads in introns or the 30 UTR. However, in the 50 UTR of FMR1
mRNA, two peaks of protected sequence were present in the
region just 50 to the CGG repeat (Figure 5A), suggesting that
fully assembled translating ribosomes do reside in this region
of FMR1 RNA in human cells. These peaks exhibited 40% of
the mean read coverage and 60% of the peak read coverage
observed in the first coding exon of FMR1 and were consistent
across three published data sets in different human cell lines
(Hsieh et al., 2012; Ingolia et al., 2012). Analysis of three mouse
cell line data sets revealed a similar set of peaks just 50 to the
CGG repeat (Figures S4C and S4D) (Guo et al., 2010; Ingolia
et al., 2011; Lee et al., 2012; Thoreen et al., 2012).
Data from studies utilizing the translational inhibitor Herringto-
nine to stall ribosomes at initiation suggest that many transcripts
contain active upstream ORFs with initiation at alternative
translational initiation sites (aTISs) (Figure S4) (Fritsch et al.,
2012; Ingolia et al., 2011). Consistent with this observation, the
average read density over the FMR1 50 UTR was comparable
Neuron
RAN Translation in FXTASto the majority of transcripts across data sets in both human and
mouse samples. We therefore focused our attention on the
enhanced read density over near-AUG codons just 50 proximal
to the repeat, given that our cell culture data wasmost consistent
with initiation in this region. We reasoned that enhanced read
density could represent pausing of assembling ribosomes at
initiation sites (Ingolia et al., 2011). The read density over two
specific near-AUG codons (iGTG 12 nt 50 to the repeat and
iCTG 24 nt 50 to the repeat) was significantly enhanced
compared to other nucleotide triplets within the FMR1 50 UTR
(Figures S4A and S4B). Similarly, the mouse fmr1 50 UTR also ex-
hibited peaks of increased RP read density just 50 proximal to the
repeat that correlated with Herringtonine-identified initiation
sites at near-AUG codons (Figures S4C and S4D). When
compared to the distribution of read densities within 50 UTRs
on a transcriptome-wide level, these sites within the FMR1/
fmr1 50 UTR demonstrate relative read densities that are compa-
rable to Herringtonine-confirmed alternative translational initia-
tion sites (Figures S4E–S4G). Taken together, these data are
consistent with translational initiation within the 50 UTR of
FMR1/fmr1 just proximal to the CGG repeat.
The FMR1 Polyglycine Protein Is Present in FXTAS
Patient Brains
Translation of a 90 CGG repeat-containing FMR1 mRNA is
predicted to produce an 11.5 kDa protein that contains an
N-terminal polyglycine stretch followed by a 42 amino acid
carboxyl terminal domain out of frame with the downstream
FMRP start codon; we named this predicted protein FMRpolyG
(Figure 5B). To determine whether FMRpolyG is made in FXTAS
patients, we developed a monoclonal antibody (2J7) against a
peptide from the predicted human protein (Figure 5B). Tested
against recombinant FMRpolyG generated in bacteria as a
GST-HIS fusion, 2J7 recognized two bands in bacterial lysates
and purified protein samples (Figure 5C) that were confirmed
by tandem MS to be FMRpolyG. In transfected mammalian
cells expressing a FLAG-tagged FMRpolyG with 55 repeats,
both 2J7 and FLAG antibody detected a protein electro-
phoresing at a slightly higher than expected MW of 16 kDa
(Figure 5D). In transfected COS cells, FLAG-FMRpolyG55
displayed diffuse nucleocytoplasmic staining with occasional
intranuclear inclusions detected by immunofluorescence with
either 2J7 or anti-FLAG antibodies (Figure 5E). 2J7 immuno-
staining also colocalized with GFP inclusions formed in cells
expressing FMRpolyG100-GFP (Figure 5F). In contrast and as
expected, 2J7 staining did not colocalize with GFP or inclu-
sions in cells expressing an expanded polyglutamine-GFP
fusion (Figure 5F).
To evaluate whether FMRpolyG is expressed in FXTAS patient
brains, we performed western blots on cerebellar lysates from
FXTAS patients. In pathologically confirmed FXTAS cases, an
15 kDa band was identified in FXTAS lysates but not in control
or AD brain lysates (Figure 5G, Figure S5E). We next evaluated
whether this antibody differentially immunostained brain tissue
from patients with clinically and pathologically confirmed
FXTAS. Immunostaining with 2J7 was much more robust in
FXTAS patient-derived hippocampal sections than in control
tissue sections and included nuclear and perinuclear aggregatesin FXTAS sections not seen in controls (Figure 5H, Figure S5A).
In FXTAS hippocampus, numerous ubiquitin-positive inclusions
were observed (Figure S6B), consistent with previous reports
(Greco et al., 2006), and these inclusions coimmunostain with
2J7 (Figure 5I, Figures S5B–S5D). In contrast, 2J7 did not
immunostain ubiquitinated polyglutamine inclusions in SCA 3
patient tissues (Figure 5I, Figure S6E). Similar staining by
western blot and immunohistochemistry was observed using a
different monoclonal antibody (2C13) against an overlapping
epitope (Figures S5F–S5L).
We also generated an additional rabbit polyclonal antibody
Ab605 raised against a larger peptide fragment of FMRpolyG
(Figure 5B). This antibody also recognizes the recombinant pro-
tein (Figure 5J). To evaluate whether Ab605 recognizes FMRpo-
lyG in inclusions in tissue, we first tested it on transverse retinal
sections of Drosophila expressing the full antibody epitope. In
flies expressing (CGG)90 GFP, Ab605 readily colocalized with
GFP+ inclusions (Figure S6A) but showed minimal staining in
flies expressing GFP alone (Figure S6A). Whereas in control
human tissue Ab605 displayed mild diffuse staining not seen in
preimmune controls, Ab605 robustly stained neurons and intra-
nuclear inclusions in FXTAS brain (Figure 5K, Figure S6C). By
immunofluorescence, Ab605 staining colocalized with ubiquitin
in FXTAS brain tissue (Figure S6D). Recognition of FXTAS
inclusions was specific, as there was no staining by Ab605 of
ubiquitinated polyglutamine inclusions in tissue sections from a
spinocerebellar ataxia 3 brain (Figure S6E).
RAN Translation of the Polyglycine Protein Explains the
Difference in Inclusion Formation between Two Mouse
Models of FXTAS
To gauge the functional consequence of expressing a cryptic
polyglycine protein, we turned to two similar mouse models
of FXTAS. In both models, one generated in the Netherlands
(Willemsen et al., 2003) and the other at the NIH (Entezam
et al., 2007), premutation repeats were inserted into the 50 UTR
of the mouse fmr1 locus. Both knockin (KI) models demonstrate
intragenerational repeat instability and some evidence of neuro-
degeneration, but their phenotypes have not been directly
compared (Brouwer et al., 2008). Comparing the cloning strate-
gies used to make both lines, we noted that the NIH mouse
model retains a greater region of mouse 50 UTR surrounding
the CGG repeat, including a TAA stop codon 18 bp 50 of the
repeat in the glycine frame (Figure 6A). This stop codon is not
present in the Dutch knockin mouse or in humans. In cell culture
experiments, placing the NIH mouse sequence, but not the
Dutch mouse sequence, just proximal to the repeat blocked
translation in the +1 (Gly) frame (Figure 6B). Thus, we would
predict expression of the novel polyglycine protein only in the
Dutch knockin mouse. Consistent with this prediction, 18-
month-old mice from both lines differ greatly in the number
and distribution of ubiquitinated inclusions. In Dutch knockin
mice, ubiquitin-positive inclusions accumulate in the hypothala-
mus, cortex, and brainstem (Figures 6C and 6D) as previously
reported (Brouwer et al., 2008), whereas they were seen less
frequently in NIH knockin mice (Figures 6C and 6D). This differ-
ence exists despite similar expression of (CGG)n fmr1 RNA in
both models (Figure 6E).Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc. 447
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Figure 5. The Predicted Polyglycine Protein Is Present in FXTAS Patient Brains
(A) Read coverage map of FMR1 locus derived from a published ribosomal profiling data set in HEK293 cells (Ingolia et al., 2012). Numbers along the x axis
represent position within the genome. y axis represents number of sequence reads at each position. Black bars represent exons, intervening sequences are
introns, and blue boxed sequences represent 50 UTR (left) and 30 UTR (right). Red box indicates the region shown at higher resolution in the bottom panel, which
includes the FMR1 50 UTR and first exon. Green and red asterisks indicate position of possible near AUG initiation codons iGUG (12 bp proximal to repeat) and
iCTG (24 bp proximal to repeat), respectively. Note significant reads over region 50 proximal to the CGG repeat sequence.
(legend continued on next page)
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RAN Translation in FXTASBecause Ab605 was raised against a peptide sequence
largely conserved in mouse, we used it to determine whether
there is divergent immunostaining for FMRpolyG protein in the
two models. Again, Dutch knockin mice show much greater
immunostaining for FMRpolyG, including punctate nuclear
staining consistent with inclusions in brain regions that also
display ubiquitin-positive inclusions (Figures 6F and 6G). By
coimmunofluorescence, Ab605 staining for FMRpolyG in Dutch
knockin mice colocalized with ubiquitin-positive inclusions
(Figure 6H). Together, these data suggest a dissociation of
pathology in the two models based on differences in the ability
to generate the polyglycine protein.
Translation of the Polyglycine Protein Contributes
to CGG Repeat Toxicity in Human Cell Lines
and Drosophila
The above results demonstrating RAN translation of a polygly-
cine protein in FXTAS models and patients support a role for
FMRpolyG in aggregate formation in FXTAS. A critical, unan-
swered question is whether this polyglycine protein contributes
to disease pathogenesis in FXTAS, or whether instead the
CGG repeat as mRNA is wholly responsible for repeat-associ-
ated neurodegeneration. We therefore evaluated the effect of
driving translation through the repeat on cell viability. Compared
to expression of GFP alone, (CGG)88 +1 GFP expression was
associated with increased cell death at 72 hr, as measured by
propidium iodide exclusion in GFP-positive cells (Figure 7A).
This toxicity was repeat length dependent (Figure S2E), consis-
tent with previous reports (Arocena et al., 2005; Sellier et al.,
2010). When translation of the polyglycine protein was enhanced
by placing an ATG upstream of the repeat, which increases pro-
duction of the polyglycine protein without altering (CGG) GFP
mRNA levels, the toxicity of the construct increased further
(Figure 7A).
Because introducing a stop codon just before the repeat elim-
inated production of HMWGFP, we reasoned that this construct
might allow us to determine whether initiating RAN translation is
required for repeat-associated toxicity. Computer modeling of
the FMR1 50 UTR RNA secondary structure predicts an energet-
ically favorable hairpin that includes the CGG repeat (Figure S3;
Napierala et al., 2005). Placement of a stop codon at 12 bp
relative to the repeat is not predicted to disrupt this hairpin (Fig-
ure S3), suggesting that CGG repeat structure should be pre-(B) Predicted sequence of human FMRpolyG protein with 90 glycines. Under
Polyglycine sequence is indicated by red box.
(C) GST and 2J7 antibody staining of recombinant purified GST-HIS-FMRpolyG3
(D) Expression of a FLAG FMRpolyG55 construct in COS cells stained with 2J7 an
expected based on predicted size. NTC, no template control. *, nonspecific ban
(E) Immunofluorescence with FLAG (green) and 2J7 (red) in COS cells expressin
(F) Coimmunofluorescence of GFP and 2J7 signal in COS cells expressing FMRp
(G) Western blot with 2J7 of cerebellar lysates from two FXTAS patients and an
samples.
(H) Representative images of 2J7 immunostaining from frontal cortex (CTX) and
(I) Coimmunofluorescence with 2J7 (green) and anti-ubiquitin (red) in FXTAS hip
subjects. In contrast, ubiquitinated inclusions in the pons of a patient with the po
(J) GST and rabbit polyclonal Ab605 staining of recombinant FMRpolyG protein.
(K) Representative images of Ab605 immunostaining of frontal cortex (CTX) and
represent 50 mm.served in this construct. We therefore measured cell death in
transfected cells expressing (CGG)88 +1 GFP or a similar
(CGG)94 +1 GFP construct containing a stop codon 12 bp before
the repeat. Inclusion of this stop codon suppressed toxicity
associated with the CGG repeat expansion, suggesting that a
component of repeat toxicity reflects production of a polyglycine
protein (Figure 7A).
To evaluate these effects in vivo, we generated a series of
Drosophila lines in which the repeat was placed in different
sequence contexts relative to GFP (Figure 7B, Table S2). We first
regenerated lines in which the CGG repeat in the 50 UTR of FMR1
is inserted upstreamofGFP in the +1 (Gly) reading frame. In other
lines, we inserted an ATG and FLAG tag just upstream of the
CGG repeat to maximally drive expression of the polyglycine
protein. To generate constructs in which the CGG repeat would
be present as RNA but not translated into protein, we took two
approaches: (1) inserting a stop codon 12 nt 50 of the CGG repeat
to prevent repeat-associated translation of the polyglycine pro-
tein, as shown earlier in cell culture (Figure 3D), or (2) moving
the CGG repeat and surrounding regions of the 50 UTR to a po-
sition downstream of GFP in the 30 UTR. In cell culture, this repo-
sitioning blocked RAN translation (Figure 7C). AllDrosophila lines
expressed 100 CGG repeats, which were stable with intergener-
ational transmission.
Differential placement of the CGG repeat modestly altered
transcript expression in Drosophila, with increased GFP mRNA
in lines containing the repeat in the 50 UTR (Figure S7A), perhaps
due to local chromatin effects (Todd et al., 2010). Accordingly,
we chose for further analysis lines in which GFP RNA production
was comparable (Figure S7A). At the protein level, placing the
CGG repeat in the 50 UTR led to less overall GFP translation
than did placement in the 30 UTR (Figure 7D). As expected,
including an ATG start codon upstream of the repeat led to
increased production of HMW GFP but decreased production
from the canonical TIS of GFP (Figure 7D).
To determine the impact of polyglycine protein expression on
neurodegenerative phenotypes, we expressed each transgene
in retinal oomatidia. In flies expressing the repeat in the 50
UTR, we again observed the appearance of ubiquitin-positive
GFP inclusions, which occurred more frequently when an ATG
was placed upstream of the repeat (Figure 7E). In lines with a
stop codon 50 to the repeat or with the repeat positioned in the
30 UTR, there were no GFP inclusions.lined regions represent peptides used to generate 2J7 and 605 antibodies.
0 protein.
d reprobed with anti-FLAG antibody and Tubulin. The protein runs higher than
d. Arrow, FLAG-positive band.
g FLAG-FMRpolyG55.
olyG100 GFP (left panels) or Q80 GFP (right panels).
age-matched control. Arrow indicates bands seen in FXTAS but not control
hippocampus (Hipp) of control and FXTAS brain.
pocampus (top two panels) or cortex (third panel) from three different FXTAS
lyglutamine disorder SCA-3 do not costain with 2J7.
Arrow indicates band recognized by GST and Ab605.
cerebellum from control and FXTAS brain. Unless otherwise noted, scale bars
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Figure 6. Sequence Differences 50 of the Repeat Explain Divergent
Inclusion Formation in Two Mouse Knockin Models of FXTAS
(A) Sequence differences in two established CGG knockin models of FXTAS
highlighting a stop codon 18 bp before the repeat present only in the NIH
mouse.
(B) Placement of the NIHmouse sequence, but not the Dutch sequence, just 50
to the repeat eliminates the HMW GFP species in the +1 (Gly) frame.
(C) Representative images (original magnification 4003, inset 1,0003) of
hypothalamus from 18-month-old NIH and Dutch knockin mice stained with
antibody to ubiquitin.
(D) Quantification of ubiquitin-positive inclusions in 18-month-old NIH and
Dutch mice in the specified brain regions.
(E) Relative expression of fmr1 mRNA in WT, NIH, and Dutch mice at 6 months
of age (n = 4/genotype).
(F) Representative images of hypothalamus from 18-month-old NIH and
Dutch knockin mice stained with Ab605 against FMRpolyG.
(G) Quantification of 605-positive inclusions in 18-month-old NIH and
Dutch mice in the specified brain regions.
(H) Confocal microscopy in the Dutch knockin mice showing colocalization
of ubiquitin and Ab605 staining inclusion in frontal cortex (left images). For (D),
n > 300 cells/brain region and >1,000 cells/genotype, *p > 0.01 on Pearson’s
chi-square test. Error bars represent 95% confidence interval for (D) and (G)
and SEM for (E).
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RAN Translation in FXTASWe next determined whether expression of these different
transgenes elicited a rough-eye phenotype as a measure of
toxicity. Placing the repeat in the 50 UTR and in-frame with
GFP resulted in a moderate rough-eye phenotype (Figures 7F,
7G, and S8C), but this same repeat elicited only a very mild
rough-eye phenotype when inserted into the 30 UTR of GFP.
Similarly, inserting a stop codon just 50 to the repeat suppressed
toxicity (Figures 7F, 7G, and S7C). In contrast, when an ATGwas
included 50 to the repeat to drive polyglycine production, the
rough-eye phenotype was more severe (Figures 7F and 7G).
These results were consistent across multiple insertion lines
(Figure S7C). When expressed ubiquitously, a CGG repeat
placed in the 50 UTR of GFP led to a decrease in viable progeny,
and inclusion of an ATG 50 of the repeat further enhanced this
toxicity (Figure 7H). In contrast, including a stop codon 50 of
the repeat or placing the repeat in the 30 UTR prevented CGG
repeat-associated alterations in viability (Figure 7H). Together,
these results suggest that RAN translation of a polyglycine pro-
tein contributes to CGG repeat toxicity in Drosophila.
DISCUSSION
Our results demonstrate that RAN translation occurs in associa-
tion with CGG repeats in the neurodegenerative disorder FXTAS,
a disease previously thought to result primarily from RNA-
mediated toxicity. These findings, along with recent reports
detailing unconventional translation through CAG repeats in
spinocerebellar ataxia type 8 and myotonic dystrophy type I
(Zu et al., 2011) and GGGGCC repeats in C9orf72-associated
ALS/FTLD (Ash et al., 2013; Mori et al., 2013), suggest that
RAN translation is a shared pathogenic mechanism in many
repeat expansion disorders. We further demonstrate that pro-
duction of one particular CGG RAN translation product in
FXTAS, FMRpolyG, directly modulates CGG-associated pathol-
ogy in two distinct model systems. First, the ability to generate
the FMRpolyG protein explains a key pathologic discrepancy
between two established knockin mouse models. Second, in
Drosophila we demonstrate that CGG repeat-associated neuro-
degeneration is largely dependent on FMRpolyG production.
These results suggest that RAN translation contributes to FXTAS
pathogenesis (Figure 8) and support an emerging view that non-
exonic repetitive elements can trigger toxicity simultaneously
as both RNA and protein.
The mechanisms underlying RAN translation remain unclear.
The unconventional translation described here appears to
initiate predominantly at a near-AUG codon just 50 proximal of
the repeat. This finding suggests a model wherein a scanning
43S ribosomal preinitiation complex stalls at the CGG repeat,
allowing for alternate usage of a near match at the initiation
codon (Figure 8). This model is based on our observation that
placing a stop codon just proximal to the repeat or shortening
the 50 leader before the repeat impairs RAN translation in this
reading frame (Figure 3). In contrast, CGG RAN translation in
the other two possible reading frames behaves differently. We
do not detect any RAN translation product from the +0 (CGG,
polyArginine) reading frame, and RAN translation in the +2
(GCG, polyAlanine) reading frame is less efficient, occurs when
stop codons are inserted 50 of the repeat, and demonstrates450 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.CGG repeat length dependence (Figures 3, 4, and 5). Differences
in the propensity for translational initiation in different reading
frames were also reported for RAN translation of expanded
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Figure 7. Production of Polyglycine Protein from CGG Repeat RNA Constructs Correlates with Toxicity in Drosophila Models
(A) COS cell viability 72 hr after transfection of (from left to right) GFP alone, (CGG)88 +1 (Gly) GFP, ATG-FLAG-(CGG)88 +1 (Gly) GFP, or Stop
@-12(CGG)94 +1 (Gly)
GFP. *p < 0.05 versus GFP alone; yp < 0.05 versus (CGG)88 GFP.
(B) Schematic of pUAST constructs used to generate fly lines with differing amounts of polyglycine protein production but identical (CGG) repeat RNA expan-
sions. Full sequences are shown in Table S2. Boxed red X, stop codon; green, GFP; red, CGG repeat; blue, other sequence; yellow, epitope tag (Flag or 6xHis tag).
(C) Placing the CGG repeat in the 30 UTR of GFP eliminates the RAN translation product. COS cells were transiently transfected with either GFP ( control),
ATG-FLAG-(CGG)100 +1 GFP (+ control), or GFP-STOP-(CGG)100-FLAG and total lysates were harvested. Blots were serially probed with antibodies to FLAG,
GFP, and actin.
(D) Lysates from Drosophila lines expressing the described constructs were probed with GFP or Tubulin. The higher MW of the ATG construct results from 150 nt
of intervening sequence between the start codon and the start of the (CGG)100 repeat.
(E) GFP inclusion formation in Drosophila eye cross-sections of the indicated genotypes.
(F) Representative images of eyes 1–2 days after eclosion with the indicated genotypes demonstrate differential toxicity across lines that is dependent on
polyglycine translation.
(legend continued on next page)
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Figure 8. Model for CGG RAN Translation
in Fragile X-Associated Tremor Ataxia
Syndrome
Ribosomes assemble on the 50 end of the FMR1
message and scan the mRNA for an appropriate
initiation sequence. Near the CGG repeat hairpin,
the 43S preinitiaton complex (red) stalls, triggering
RAN translational initiation at a near-AUG codon.
Once translation initiates, the ribosome reads
through the repeat to produce a polyglycine-con-
taining protein. Normally, this peptide is readily
cleared from cells, but with larger repeats the re-
sultant expanded polyglycine protein accumulates
in inclusions. The downstream AUG start site for
FMRP is not in frame with the polyglycine protein;
thus, no N-terminal addition onto FMRP occurs
with this CGG RAN translation. Trailing ribosomes
(green) may not stall at the hairpin but instead
initiate translation normally at the AUG for FMRP.
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RAN Translation in FXTASCAG repeats in SCA 8, in which the surrounding sequence
appeared to be an important modulator (Zu et al., 2011). Thus,
RAN translation may not result from a single mechanism. Rather,
each repeat, and indeed each reading frame within each repeat,
may have different contextual requirements. These differences
notwithstanding, the fact that atypical translation has now
been observed independently with four different nucleotide
RNA repeats in cell lines, animal models, and human tissues
suggests that it is a more widespread biological event than
anticipated.
An emerging question now is what roles do these translation
initiation events play in normal physiology and in disease? Our
findings support a significant role for the FMRpolyG protein in
disease pathogenesis, given the evidence in Drosophila and(G) Quantification of the rough-eye phenotypes associated with the indicated genotypes demonstrates sign
polyglycine translation and reduced toxicity in lines in which CGG RAN translation is blocked.
(H) Ubiquitous expression of CGGGFP transgenes in the 50 UTR decreases fly viability as measured by progen
in CGG 50 stop lines and CGG 30 UTR lines but the constructs are more toxic in ATG-CGG GFP lines in which p
and (H), *p < 0.05 versus 30 UTR or GFP; yp < 0.05 versus 50 UTR. Error bars represent SEM.
452 Neuron 78, 440–455, May 8, 2013 ª2013 Elsevier Inc.mammalian cells of enhanced toxicity
with increased polyglycine translation
and lessened toxicity when translation is
reduced. However, numerous published
studies support a primary role for CGG
RNA in toxicity (Arocena et al., 2005;
Hashem et al., 2009; Jin et al., 2007;
Sellier et al., 2010; Sofola et al., 2007),
leading us to suggest that, in FXTAS,
additive or synergistic toxicity associated
with both toxic RNA and toxic proteins
may be critical to disease pathogenesis.
Though we have focused on FMRpolyG
production, other CGG RAN translation-
associated products such as the polyala-
nine protein could represent additional
toxic species. Moreover, if RAN transla-
tion occurs with CCG repeats, then pro-duction of other homopolymeric proteins from the antisense
transcript through the repeat could also be relevant (Ladd
et al., 2007). For all of these potentially toxic entities, it will be
important to determine their relative production in patients and
relative degree of toxicity in animal models to ascertain their
roles in disease pathogenesis.
CGG RAN translation may also play a normal physiological
role in translational regulation of FMR1mRNA. FMRP, the protein
product of FMR1, critically regulates synaptic function and its
loss leads to fragile X syndrome, a common cause of autism
and mental retardation. FMR1 mRNA is rapidly translated at
synapses in an activity-dependent manner, where it constrains
local synaptic protein translation (Penagarikano et al., 2007).
Our results in transfected cells show that RAN translation canificantly enhanced toxicity in lines with enhanced
y eclosion ratios. This change in viability is blocked
olyglycine protein production is enhanced. For (G)
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RAN Translation in FXTASoccur at normal repeat sizes, with initiation occurring within a
narrow region just 50 of the repeat (Figure 8). Analysis of ribo-
somal profiling data sets derived from samples with normal
CGG repeat sizes demonstrates the presence of assembled
ribosomes over these regions in both human and mouse cell
lines (Figures 5 and S5; Ingolia et al., 2011). Intriguingly, the
Drosophila homolog of FMRP, dfxr, is expressed as two iso-
forms, with the larger isoform initiating translation at a CUG
codon upstream of the canonical TIS, indicating that aspects
of this process may be evolutionarily conserved (Beerman and
Jongens, 2011). Upstream ORFs are believed to suppress
expression from downstream canonical ORFs (Chatterjee and
Pal, 2009). In the case of FMR1 mRNA, translation through the
repeat may assist RNA unwinding via helicase recruitment,
allowing normal scanning by trailing ribosomes and appropriate
initiation at the canonical ORF (Figure 8). Alternatively, ribo-
somes translating through the repeat could terminate translation
and reinitiate at the AUG of FMRP, or ribosomes could initiate
downstream of the repeat via an internal ribosomal entry site
(Ludwig et al., 2011).
Variations on the RAN translation described here potentially
could expand the percentage of the transcriptome encoding
for protein, complicating the classical definitions by which we
divide ‘‘coding’’ from ‘‘noncoding’’ RNA. Consistent with this,
recent unbiased methods in yeast and mammalian cells reveal
that thousands of transcripts initiate translation at non-AUG start
sites, often creating upstream ORFs in sequences previously
identified as 50 UTR (Ingolia et al., 2011; Ivanov et al., 2011).
Usage of these atypical upstream ORFs is responsive to
changes in cell state and external stimuli (Brar et al., 2012).
Mechanisms similar to those reported here may therefore have
broader repercussions for the neuronal proteome and global
translational regulation.
EXPERIMENTAL PROCEDURES
Fly Stocks
Drosophila lines used in Figures 1 and S1 of this study have been previously
described in Jin et al. (2003), Pandey et al. (2007), and Todd et al. (2010).
Details of construction of new fly lines are in the Supplemental Experimental
Procedures and Table S2. Unless stated otherwise, all crosses were done
and maintained on standard food at 25C. For (CGG)90 GFP lines, stability of
theCGG repeat was confirmed by PCR and sequencing using C and F primers.
Plasmid Constructs for Cell Culture Experiments
Cell culture expression plasmids were derived fromCMV-(CGG)88-GFP, a kind
gift from Paul Hagerman (Arocena et al., 2005) or were PCR cloned from
patient-derived cell lines. Sequence variants were generated from this
vector by site-directed mutagenesis (Stratagene) according to manufacturer’s
protocols. All vector sequences were confirmed by Sanger sequencing and
are described in detail in Table S1.
Lysostaphin Protease Digestion
Immunoprecipitation with anti-GFP agarose beads was conducted as
described in the Supplemental Experimental Procedures. Prior to elution,
the beads were washed 23 in RIPA without protease inhibitors and then in
20 mM Tris-HCl buffer at pH 7.5 without protease inhibitors. The agarose
beads were then incubated with 0.1 mg/ml Lysostaphin (Sigma) in Tris
buffer or in Tris buffer alone with agitation at room temperature for 3 or
20 hr. The beads were then washed 1 3 5 min with RIPA buffer and eluted
with Laemmli buffer.Antibody Generation
Monoclonal mouse antibodies 2J7 and 2C13 were developed commercially
(Abmart) against a 10 amino acid peptide, LAGLKRRWRS, in the predicted
carboxyl terminus of the FMR1polyG. The epitope is predicted to be present
in human patient samples, with a near match (8/10 AA) to the original
(CGG)90 GFP Drosophila lines, but not the newly constructed Drosophila lines
or the transfection vector constructs used in Figures 2, 3, and 4. The epitope is
effectively absent (5/10 AA match) from both mouse KI models. Rabbit poly-
clonal antibody Ab605 was generated commercially (Rockland) against a
larger peptide (GLKRRWRSWWWKCGAP) that overlaps more significantly
with the predicted sequence in Drosophila (16/17) and in both mouse lines
(13/17).
Human Tissue
All human tissues were obtained and distributed under oversight by appro-
priate institution specific review boards. Detailed methods and descriptions
of the patient derived samples are included in the Supplemental Experimental
Procedures. Briefly, hippocampal, cerebellar, and frontal cortex tissue from
two previously described FXTAS patients (Louis et al., 2006) and age- and
sex-matched controls (University of Michigan Alzheimer’s Disease Brain
Bank) were processed using standard techniques. CGG repeat size was
determined in both controls and FXTAS patients by DNA isolation followed
by PCR using C and F primers.
Statistical Analysis
For graphs of percentages, error bars represent the 95% confidence interval
(CI). For all other graphs, error bars represent SEM. For statistical analyses
of nonparametric measurements of viability and inclusions, a chi-squared
test was performed. For all other analyses, a one-way ANOVA was performed,
with post hoc Dunnet’s test for multiple comparisons when applicable.
Ribosomal profiling data set analysis is detailed in the Supplemental
Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.03.026.
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